The Centers for Medicare & Medicaid Services should determine the extent to which state Medicaid programs comply with federal requirements to cover medication-assisted treatment in all formats, and take actions as appropriate to ensure compliance, the Government Accountability Office said in a report released today. Congress asked GAO to review access barriers to MAT medications. GAO found that some state policies, such as prior authorization requirements and mandated distribution methods, can restrict Medicaid beneficiaries' access to MAT. 

Related News Articles

Headline
The White House June 6 issued a memorandum directing the Secretary of the Department of Health and Human Services “to take appropriate action to eliminate…
Headline
A Congressional Budget Office report released June 4 found that enactment of the fiscal year 2025 budget reconciliation bill, the One Big Beautiful Bill Act (H…
Headline
The AHA June 3 launched the first in a new video series, “Medicaid: Real Lives, Real Care,” highlighting the importance of Medicaid and why proposed cuts…
Headline
The Wall Street Journal today published online a letter to the editor from AHA President and CEO Rick Pollack responding to a recent editorial, “The…
Perspective
Public
After approval in the House last week by a one vote margin, the One Big Beautiful Bill Act — a sweeping package that would enact many of President Trump’s…
Headline
The Centers for Medicare & Medicaid Services May 27 announced it will increase oversight of states to prevent the misuse of federal Medicaid funding to…